Fulvestrant and Palbociclib
About
Membership operator: AND
Therapies: 2
Therapies
Fulvestrant (tx:ncit:C1379)
Palbociclib (tx:ncit:C49176)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (4) | ER positive, HER2-negative | Invasive Breast Carcinoma | Fulvestrant, Palbociclib | |
| EMA (2) FDA (4) | HER2-negative, PR positive | Invasive Breast Carcinoma | Fulvestrant, Palbociclib | |
| EMA (2) FDA (4) | ER positive, HER2-negative, PR positive | Invasive Breast Carcinoma | Fulvestrant, Palbociclib |